🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 501976104
- IPO
- 2/8/2024 · $22/share
Business: Kyverna Therapeutics, Inc. is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.
Company Contact
- CEO
- Warner Biddle
- CFO
- Ryan Jones
- Headquarters
- 5980 Horton St., STE 550, Emeryville, CA 94608
- Phone
- 510-925-2492